1 J.P. Craig, K.K. Nichols, E.K. Akpek, et al.TFOS DEWS II definition and classification report Ocul Surf, 15 (3) (2017), pp. 276-283, 10.1016/j.jtos.2017.05.008

2 L.M. Nijm, G.E. DunbarUnderstanding the science behind the inflammatory cascade of dry eye disease US Ophthalmic Review, 12 (1) (2019), p. 15, 10.17925/usor.2019.12.1.15

3 S.C. Pflugfelder, W.J. Farley, L. Luo, et al.Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye Am J Pathol, 166 (1) (2005), pp. 61-71, 10.1016/s0002-9440(10)62232-8

4 R. SamburskyPresence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye Clin Ophthalmol, 10 (2016), pp. 2337-2343, 10.2147/opth.s12125

5 X. Li, B. Kang, Y. Eom, et al.The protective effect of an eye wash solution on the ocular surface damage induced by airborne carbon black exposure Cornea, 39 (8) (2020), pp. 1040-1047, 10.1097/ico.0000000000002304

6 A. Kim, C.K. Postnikoff, K.K. NicholsNon Pharmaceutical eye wash may reduce Matrix Metalloprotease-9 (MMP-9) in dry eye Invest Ophthalmol Vis Sci, 61∗ (7) (2020), p. 100

7 M. Diaz-Llopis, M.D. Pinazo-Duran, L. Diaz-Guiñon, et al.A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome Clin Ophthalmol, 13 (2019), pp. 483-490, 10.2147/OPTH.S185409

8 D. Manuel, P. Dolores, D. Loreto, et al.Efficacy of isotonic seawater solution on inflammation of the ocular surface in matrix metalloproteinase MMP-9-positive dry eye disease patients Open J Ophthalmol, 10 (2020), pp. 211-219, 10.4236/ojoph.2020.103023

9 W.R. Bloom, S.S.A. KondapalliUtility of a novel eyelid retractor and irrigation instrument in minimizing patient-reported discomfort after intravitreal injection Retina, 43 (9) (2023), pp. 1633-1635, 10.1097/IAE.0000000000003124

10 H.B. Mohamed, B.N. Abd El-Hamid, D. Fathalla, et al.Current trends in pharmaceutical treatment of dry eye disease: a review Eur J Pharmaceut Sci, 175 (2022), Article 106206, 10.1016/j.ejps.2022.106206

11 InflammaDry Test Procedure. (n.d.). Retrieved August 13, 2023, from https://www.quidel.com/sites/default/files/product/documents/EF1344100EN00.pdf.

12 M. Kim, J.Y. Oh, S.H. Bae, et al.Assessment of reliability and validity of the 5-scale grading system of the point-of-care immunoassay for tear matrix metalloproteinase-9 Sci Rep, 11 (2021), Article 12394, 10.1038/s41598-021-92020-6

13 M.A. Birkett, S.J. DayInternal pilot studies for estimating sample size Stat Med, 13 (23–24) (1994), pp. 2455-2463, 10.1002/sim.4780132309

14 R.A. Sack, A. Beaton, S. Sathe, et al.Towards a closed eye model of the pre-ocular tear layer Prog Retin Eye Res, 19 (6) (2000), pp. 649-668, 10.1016/s1350-9462(00)00006-9

15 C.S. de Paiva, A.J. St Leger, R.R. CaspiMucosal immunology of the ocular surface Mucosal Immunol (2022), 10.1038/s41385-022-00551-6

16 J. Pinto-Fraga, M. Calonge, A. Enríquez-de-Salamanca, et al.Development of a questionnaire for detecting changes in dry eye disease–related symptoms Eye Contact Lens, 47∗ (1) (2020), pp. 8-14, 10.1097/icl.0000000000000693

17 J.C. Zarzuela, R. Reinoso, A. Armentia, et al.Conjunctival intraepithelial lymphocytes, lacrimal cytokines and ocular commensal microbiota: analysis of the three main players in allergic conjunctivitis Front Immunol, 13 (2022), Article 911022, 10.3389/fimmu.2022.911022

18 W.R. Bloom, J.P. Mathias, S.S.A. KondapalliAcute management of ocular chemical injury using a combination eyelid retraction and irrigation instrument Advances in Ophthalmology and Practice Research, 1 (1) (2021), Article 100003, 10.1016/j.aopr.2021.100003

19 M. Zemba, M.A. Ionescu, R.A. Pîrvulescu, et al.Biomarkers of ocular allergy and dry eye disease Romanian Journal of Ophthalmology, 67 (3) (2023), pp. 250-259, 10.22336/rjo.2023.42